{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Amentoflavone", "apoptosis", "invasion", "non-small cell lung cancer", "nuclear factor-kappa B"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33788727", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "12"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "12"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.21873/anticanres.14893"], "Journal": {"ISSN": "1791-7530", "JournalIssue": {"Volume": "41", "Issue": "3", "PubDate": {"Year": "2021", "Month": "Mar"}}, "Title": "Anticancer research", "ISOAbbreviation": "Anticancer Res"}, "ArticleTitle": "Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells.", "Pagination": {"StartPage": "1357", "EndPage": "1364", "MedlinePgn": "1357-1364"}, "Abstract": {"AbstractText": ["Amentoflavone, an effective compound derived from medicinal plants, has been shown to boost therapeutic efficacy of chemotherapy in non-small cell lung cancer (NSCLC). However, anti-NSCLC effect of amentoflavone is ambiguous. The major purpose of the present study was to verify the inhibitory effects of amentoflavone in NSCLC cells.", "The effects of amentoflavone on growth and invasion of NSCLC CL-1-5-F4 cells were evaluated by cell viability assay, flow cytometry, colony formation assay, nuclear factor-kappa B (NF-\u03baB) reporter gene assay, immunofluorescence staining, transwell invasion, and western blot assay.", "Amentoflavone effectively induced cell growth inhibition, G1 cell-cycle arrest, apoptosis, and suppression of invasion. Furthermore, amentoflavone not only triggered expression of p27, cleaved caspase-3, -8 also reduced NF-\u03baB signaling, protein levels of matrix metalloproteinase (MMP)-2, -9, Cyclin-D1, and vascular endothelial growth factor (VEGF).", "Cell-cycle arrest, apoptosis induction, NF-\u03baB signaling inhibition are associated with amentoflavone-inhibited growth and invasion of NSCLC cells."], "CopyrightInformation": "Copyright \u00a9 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, R.O.C."}], "LastName": "Chen", "ForeName": "Wei-Ting", "Initials": "WT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Surgical department of Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C."}], "LastName": "Chen", "ForeName": "Cheng-Hsien", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Anesthesiology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan, R.O.C."}, {"Identifier": [], "Affiliation": "School of Medicine, Tzu Chi University, Hualien, Taiwan, R.O.C."}], "LastName": "Su", "ForeName": "Hung-Tai", "Initials": "HT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Traditional Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C."}, {"Identifier": [], "Affiliation": "Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C."}], "LastName": "Yueh", "ForeName": "Po-Fu", "Initials": "PF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C."}], "LastName": "Hsu", "ForeName": "Fei-Ting", "Initials": "FT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.; john740604@yahoo.com.tw."}, {"Identifier": [], "Affiliation": "Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C."}, {"Identifier": [], "Affiliation": "Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C."}], "LastName": "Chiang", "ForeName": "I-Tsang", "Initials": "IT"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Anticancer Res", "NlmUniqueID": "8102988", "ISSNLinking": "0250-7005"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biflavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Endothelial Growth Factor A"}, {"RegistryNumber": "9I1VC79L77", "NameOfSubstance": "amentoflavone"}, {"RegistryNumber": "EC 3.4.24.-", "NameOfSubstance": "Matrix Metalloproteinases"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biflavonoids"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"QualifierName": [], "DescriptorName": "G1 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Matrix Metalloproteinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Neoplasm Invasiveness"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Vascular Endothelial Growth Factor A"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "1", "Day": "11"}, {"Year": "2021", "Month": "1", "Day": "21"}, {"Year": "2021", "Month": "1", "Day": "22"}, {"Year": "2021", "Month": "3", "Day": "31", "Hour": "17", "Minute": "14"}, {"Year": "2021", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33788727", "10.21873/anticanres.14893", "41/3/1357"]}}], "PubmedBookArticle": []}